Early research (Phase 1)Study completedNCT01682616
What this trial is testing
A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Who this might be right for
Small Lymphocytic LymphomaChronic Lymphocytic Leukemia
AbbVie 49